Loading...
BVMF
ONCO3
Market cap232mUSD
Oct 16, Last price  
1.04BRL
1D
5.05%
1Q
33.33%
IPO
-94.41%
Name

Oncoclinicas do Brasil Servicos Medicos SA

Chart & performance

D1W1MN
BVMF:ONCO3 chart
P/E
—
P/S
0.21
EPS
—
Div yield, %
—
Shs. 5Y
10.91%
Rev. 5Y
23.04%
Revenues
5.74b
-7.83%
269,135,000359,453,000457,971,000594,811,000791,837,0001,050,836,0001,689,510,0002,035,191,0002,702,066,0004,088,252,0005,488,776,0006,227,227,0005,739,367,000
Net income
-3.62b
L+460.79%
20,504,000-22,165,000-24,768,000-25,358,0003,145,000-17,078,000-20,417,000-157,687,000-46,900,00046,260,000223,618,000-646,190,000-3,623,788,000
CFO
-103m
L-44.19%
7,342,0009,285,000-3,097,000-20,706,000135,259,00038,859,00097,075,000185,565,000-9,283,000-271,644,000-51,563,000-184,851,000-103,168,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Oncoclínicas do Brasil Serviços Médicos S.A., together with its subsidiaries, provides oncology, hematology, radiotherapy, and genomics healthcare services in Latin America. The company offers treatment services, including radiotherapy, hormone therapy, immunotherapy, port-a-cath, palliative care, target therapy, breast cancer hormone therapy, bone marrow transplant, non-oncological infusions, chemotherapy, oral chemotherapy, and prostate cancer hormone therapy; and surgery procedures, such as breast, head and neck, lung, prostate cancer, stomach, bladder cancer, oncological, kidney cancer, gynecological, and testicular cancer. It also provides diagnostics services comprising pathological analysis, genetic testing, molecular journey, personalized medicine and individualized treatment, myelogram-bone marrow biopsy, and ONCO test-PDO. In addition, the company offers treatment support services, which include veinviewer, cryotherapy, integrative medicine, and DeLife, as well as hilotherapy, laser therapy, OC care line, OC precision medicine, OncoACCESS, survivorship, and telemedicine services. Oncoclínicas do Brasil Serviços Médicos S.A. was founded in 2010 and is headquartered in São Paulo, Brazil.
IPO date
Aug 10, 2021
Employees
Domiciled in
BR
Incorporated in
BR

Valuation

Title
BRL in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT